SCHEMBL15380533

SCHEMBL15380533

CS(=O)(=O)Nc1ccc(C2(C(=O)N[C@H](CN3CCCC3)c3ccccc3)CC2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
GPR88 Q9GZN0 1/20 0.40
OPRK1 P41145 5/20 0.39
OPRM1 P35372 3/20 0.39
OPRD1 P41143 3/20 0.39
CYP2D6 P10635 2/20 0.37
RPS6KB1 P23443 2/20 0.37
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
ITGA4 P13612 1/20 0.37
ITGB7 P26010 1/20 0.37
MAPK1 P28482 2/20 0.36
NPC1 O15118 1/20 0.36
SCN1A P35498 2/20 0.36
SCN5A Q14524 2/20 0.36
SCN8A Q9UQD0 2/20 0.36
MITF O75030 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL432353 1.00 ROCK2 (0.41) ROCK2ROCK1GPR88OPRK1OPRM1
SCHEMBL10083352 0.87 OPRK1 (0.42) GPR88OPRK1OPRM1OPRD1CYP2D6
SCHEMBL433167 0.87 OPRK1 (0.42) GPR88OPRK1OPRM1OPRD1CYP2D6
SCHEMBL434123 0.83 OPRK1 (0.39) ROCK2ROCK1GPR88OPRK1OPRM1
SCHEMBL432530 0.83 OPRK1 (0.39) ROCK2ROCK1GPR88OPRK1OPRM1
SCHEMBL15386626 0.83 OPRK1 (0.39) ROCK2ROCK1GPR88OPRK1OPRM1
SCHEMBL15385518 0.83 OPRK1 (0.39) ROCK2ROCK1GPR88OPRK1OPRM1
SCHEMBL10083346 0.82 CCR2 (0.43) ROCK2ROCK1GPR88OPRK1OPRM1
SCHEMBL435448 0.82 CCR2 (0.43) ROCK2ROCK1GPR88OPRK1OPRM1
SCHEMBL10083993 0.82 OPRK1 (0.47) GPR88OPRK1OPRM1OPRD1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9303027-B2 Kappa opioid receptor agonists DR. REDDY'S LABORATORIES LTD. (IN) 2016-04-05 US claimed
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US claimed
US-9303027-B2 Kappa opioid receptor agonists DR. REDDY'S LABORATORIES LTD. (IN) 2016-04-05 US disclosed
US-9303027-B2 Kappa opioid receptor agonists DR. REDDY'S LABORATORIES LTD. (IN) 2016-04-05 US disclosed
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US disclosed
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS OPRK1, OPRL1, OPRD1 ROCK2 1728/4885ROCK1 1088/4885GPR88 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.